Study ID: CA43-SFY17915 for Atopic Dermatitis (Eczema)
Summary
Welcome to the SimcoDerm Clinical Trials recruiting website for an atopic dermatitis (eczema) medical research study.
In this research study we are evaluating an investigational eczema medication to see how it may affect common vaccinations, and how well and safely it works when given with those vaccines. We are currently enrolling qualified participants.
Qualifications for study participation include:
• Volunteers must be 18 years of age or above
• Volunteers must have eczema affecting at least 10% of the skin surface
• Volunteers must have had unsatisfactory symptom improvement from, or been unable to tolerate, eczema treatment in the past 6 months.
There is no cost to participate. Qualified participants will have regular visits with study doctors who specialize in treating atopic dermatitis. Participation will last about 36 weeks and involve about 7 visits to the study research site.
Participants who satisfy applicable requirements may be reimbursed for study-related expenses (e.g. meal(s) and transportation/parking).
Study Details
| Study Name | Age Requirements | Length of Study | Type of Treatment |
|---|---|---|---|
|
CA43-SFY17915 |
18+ |
36 Weeks (7 visits to the clinic) |
Injection |
Welcome to the SimcoDerm Clinical Trials recruiting website for an atopic dermatitis (eczema) medical research study.
In this research study we are evaluating an investigational eczema medication to see how it may affect common vaccinations, and how well and safely it works when given with those vaccines. We are currently enrolling qualified participants.
Qualifications for study participation include:
• Volunteers must be 18 years of age or above
• Volunteers must have eczema affecting at least 10% of the skin surface
• Volunteers must have had unsatisfactory symptom improvement from, or been unable to tolerate, eczema treatment in the past 6 months.
There is no cost to participate. Qualified participants will have regular visits with study doctors who
specialize in treating atopic dermatitis. Participation will last about 36 weeks and involve about 7 visits
to the study research site.
Participants who satisfy applicable requirements may be reimbursed for study-related expenses (e.g. meal(s) and transportation/parking).
Contact us about joining the trial
Fill out this form to get in touch. We will contact you in 1-2 business days regarding your application to participate in the trial.